Combination of bortezomib plus ruxolitinib in steroid-refractory chronic graft-versus-host disease

Detalles Bibliográficos
Autores principales: Kaloyannidis, Panayotis, Shaibani, Eshrak Al, Apostolidis, Ioannis, Kanfar, Solaf, Anezi, Khalid Al, Hashmi, Hani Al
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6760676/
https://www.ncbi.nlm.nih.gov/pubmed/30337698
http://dx.doi.org/10.1038/s41409-018-0362-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6760676/
https://www.ncbi.nlm.nih.gov/pubmed/30337698
http://dx.doi.org/10.1038/s41409-018-0362-7

Ejemplares similares